![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Century Therapeutics Inc | NASDAQ:IPSC | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.18 | -5.71% | 2.97 | 2.85 | 3.50 | 3.18 | 2.96 | 3.18 | 152,741 | 23:01:05 |
| | | | | 1 | | | |
| | | | | 2 | | | |
| | | | | 4 | | | |
| | | | | 7 | | | |
| | | | | 8 | | | |
| | | | | 9 | | | |
| | | | | 12 | | | |
| | | | | 14 | | | |
| | | | | 17 | | | |
| | | | | 18 | | | |
| | | | | 19 | | | |
| | | | | 19 | | |
| | |
Number of Shares of
Common Stock Owned Prior to Offering |
| |
Maximum Number
of Shares of Common Stock to be Sold Pursuant to this Prospectus |
| |
Number of Shares of
Common Stock Owned After Offering(1) |
| |||||||||||||||||||||
Name of Selling Stockholder
|
| |
Number
|
| |
Percent
|
| |
Number
|
| |
Percent
|
| ||||||||||||||||||
Bain Capital Life Sciences Opportunities III,
LP(2) |
| | | | 5,410,361 | | | | | | 6.5% | | | | | | 5,291,005 | | | | | | 119,356 | | | | | | * | | |
Adage Capital Partners LP(3)
|
| | | | 1,322,751 | | | | | | 1.6% | | | | | | 1,322,751 | | | | | | 0 | | | | | | * | | |
Entities affiliated with Casdin Capital, LLC(4)
|
| | | | 5,190,506 | | | | | | 6.2% | | | | | | 1,984,126 | | | | | | 3,215,380 | | | | | | 3.9% | | |
Entities affiliated with Venrock Healthcare Capital Partners EG, L.P.,(5)
|
| | | | 5,389,259 | | | | | | 6.5% | | | | | | 1,984,126 | | | | | | 3,405,133 | | | | | | 4.1% | | |
Entities affiliated with Boxer Capital,
LLC(6) |
| | | | 5,080,177 | | | | | | 6.1% | | | | | | 3,174,603 | | | | | | 1,905,574 | | | | | | 2.3% | | |
Entities affiliated with Superstring Capital Master Fund LP(7)
|
| | | | 925,925 | | | | | | 1.1% | | | | | | 925,925 | | | | | | 0 | | | | | | * | | |
| | |
Number of Shares of
Common Stock Owned Prior to Offering |
| |
Maximum Number
of Shares of Common Stock to be Sold Pursuant to this Prospectus |
| |
Number of Shares of
Common Stock Owned After Offering(1) |
| |||||||||||||||||||||
Name of Selling Stockholder
|
| |
Number
|
| |
Percent
|
| |
Number
|
| |
Percent
|
| ||||||||||||||||||
Octagon Investments Master Fund LP(8)
|
| | | | 1,333,650 | | | | | | 1.6% | | | | | | 793,650 | | | | | | 540,000 | | | | | | * | | |
Entities affiliated with DAFNA Capital Management LLC(9)
|
| | | | 1,704,232 | | | | | | 2.1% | | | | | | 396,825 | | | | | | 1,307,407 | | | | | | 1.6% | | |
1 Year Century Therapeutics Chart |
1 Month Century Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions